info@cancercarespecialtiesmena.com
Humaid O. Al-Shamsi1, Bryan K. Kee1, Michael T. Tetzlaff2, Robert A. Wolff1 Department of Gastrointestinal Medical Oncology, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA Correspondence to: Humaid O. Al-Shamsi. Assistant Professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson
Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab Humaid O. Al-Shamsi1,2,3, Abdulaziz Al Farsi1, Mahraz Anjum2, Hua Shen2, Kevin Zbuk1, Richard J. Cook2, Lori-Ann Linkins4, Pierre Major1 1Department of Oncology, McMaster University, Hamilton, Ontario, Canada; 2Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada;